This trial will study how well sotrovimab works in young people with mild to moderate COVID-19 who are at risk of disease progression.
9 Primary · 3 Secondary · Reporting Duration: Baseline, at Day 5, Day 8 and Day 11
2 Treatment Groups
Cohort B: Participants receiving sotrovimab via Intramuscular administration
1 of 2
Cohort A: Participants receiving sotrovimab via Intravenous administration
1 of 2
72 Total Participants · 2 Treatment Groups
Primary Treatment: Sotrovimab · No Placebo Group · Phase 2
Who is running the clinical trial?
Age No minimum age - 18 · All Participants · 3 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are medical professionals currently seeking participants for this research endeavor?
"Per the clinicaltrials.gov database, this clinical trial is actively recruiting participants at present and was initially posted on December 16th 2021 with a recent update of November 4th 2022." - Anonymous Online Contributor
Is the scope of this medical trial open to participants 55 and over?
"This clinical trial has stringent age requirements, with participants needing to be no younger than 0 days and no older than 18 years of age." - Anonymous Online Contributor
What is the scope of participants for this clinical research?
"Affirmative. According to the data accessible on clinicaltrials.gov, this medical study, that was inaugurated on December 16th 2021 is currently recruiting participants. For completion of the trial 72 patients must be recruited from 7 distinct facilities." - Anonymous Online Contributor
What medical conditions does Sotrovimab usually address?
"Sotrovimab is a medication utilized in cases of positive results from direct sarscov-2 viral testing, proclivity to progress towards severe Covid-19 and/or hospitalization, weight 40kg or more, as well as mild to moderate Covid-19." - Anonymous Online Contributor
Are there multiple locations where this experimentation is taking place?
"At present, this medical trial is recruiting participants from 7 different sites. Locations include Idaho Falls, Houston and Cullman amongst other centres. To alleviate the burden of travel for patients that choose to enroll in the study, it's recommended they select a clinic near them." - Anonymous Online Contributor
What criteria must a person fulfill to be eligible for this medical experiment?
"This research requires 72 subjects aged 0 Days to 18 years that have been confirmed with covid-19. Additionally, participants must meet one of the following criteria: be under 1 year old; suffer from diabetes mellitus; possess a genetic or metabolic disorder; obesity, cardiovascular disease, sickle cell anemia, pulmonary illness, neurological condition; immunocompromised state or baseline medical complexity (i.e. gastrostomy/jejunostomy dependence and usage of CPAP/BiPAP)." - Anonymous Online Contributor
Are there any other investigations that have utilized Sotrovimab?
"Presently, there are 4 clinical trials involving Sotrovimab that are in progress with two of them currently at Phase 3. Most of the experiments for this medication are based in Pretoria, Gauteng; however, it is also possible to participate across 270 other locations worldwide." - Anonymous Online Contributor
Has Sotrovimab gained the endorsement of the Food and Drug Administration?
"The safety profile of Sotrovimab was rated a 2, as it has been tested to some degree but there is no evidence demonstrating its efficacy." - Anonymous Online Contributor